Langasog, Rudy S.
HRN: 23-51-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/08/2023
08/13/2023
IV
2.25gm
Q12H
CAP MR
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines